22nd Century Group Inc. logo

XXII

AMEX

22nd Century Group Inc.

SectorHealth CareIndustry Medicinal Chemicals and Botanical Products
$1.71-0.33 (-15.97%)
Website
News25/Ratings4

22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

News · 26 weeks39-14%
2025-10-26: 12025-11-02: 42025-11-09: 82025-11-16: 02025-11-23: 02025-11-30: 02025-12-07: 32025-12-14: 22025-12-21: 02025-12-28: 12026-01-04: 12026-01-11: 22026-01-18: 12026-01-25: 02026-02-01: 02026-02-08: 02026-02-15: 22026-02-22: 12026-03-01: 02026-03-08: 02026-03-15: 12026-03-22: 62026-03-29: 12026-04-05: 32026-04-12: 12026-04-19: 1
2025-10-262026-04-19
Mix1690d
  • SEC Filings10(63%)
  • Other4(25%)
  • Earnings1(6%)
  • Dividends1(6%)

Latest news

25 items